-
1
المؤلفون: Xiaoqian Zhai (9450832), Qiang Wu (31071), Dan Pu (3714616), Liyuan Yin (1834954), Weiya Wang (85533), Daxing Zhu (190488), Feng Xu (89016)
مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, ALK fusion, ALK-GCA and EML4-ALK, stage IIIB-N2 NSCLC, alectinib, adjuvant targeted therapy
-
2صورة
المؤلفون: Xiaoqian Zhai (9450832), Qiang Wu (31071), Dan Pu (3714616), Liyuan Yin (1834954), Weiya Wang (85533), Daxing Zhu (190488), Feng Xu (89016)
مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, ALK fusion, ALK-GCA and EML4-ALK, stage IIIB-N2 NSCLC, alectinib, adjuvant targeted therapy
-
3
المؤلفون: Xiaoqian Zhai (9450832), Jiewei Liu (488795), Zuoyu Liang (11017740), Zhixi Li (847419), Yanyang Liu (713205), Lin Huang (288599), Weiya Wang (85533), Feng Luo (47640)
مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, immunotherapy resistance, targeted therapy resistance, epidermal growth factor receptor mutation, high PD-L1 expression, tyrosine kinase inhibitors, lung adenocarcinoma, small cell cancer transformation